Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons.
D000818:Animals; D002247:Carbon Isotopes; D005246:Feedback; D006213:Hallucinogens / Q000494:pharmacology*; D006651:Histocytochemistry; D066298:In Vitro Techniques; D008297:Male; D008856:Microscopy, Fluorescence; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D011562:Psilocybin / Q000494:pharmacology; D051381:Rats; D012018:Reflex / Q000187:drug effects; D011984:Sensory Receptor Cells / Q000187:drug effects; D012701:Serotonin / Q000378:metabolism; D014363:Tryptamines / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology*
D002247:Carbon Isotopes; D006213:Hallucinogens; D008996:Monoamine Oxidase Inhibitors; D014363:Tryptamines; D011562:Psilocybin; D012701:Serotonin